Current drugs to treat infections with herpes simplex viruses-1 and-2
LA Sadowski, R Upadhyay, ZW Greeley, BJ Margulies - Viruses, 2021 - mdpi.com
Herpes simplex viruses-1 and-2 (HSV-1 and-2) are two of the three human
alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in …
alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in …
Metabolic efficacy of phosphate prodrugs and the remdesivir paradigm
AJ Wiemer - ACS Pharmacology & Translational Science, 2020 - ACS Publications
Drugs that contain phosphates (and phosphonates or phosphinates) have intrinsic
absorption issues and are therefore often delivered in prodrug forms to promote their uptake …
absorption issues and are therefore often delivered in prodrug forms to promote their uptake …
Pronucleotides of 2′, 3′-Dideoxy-2′, 3′-Didehydrothymidine as Potent Anti-HIV Compounds
X Jia, D Schols, C Meier - Journal of Medicinal Chemistry, 2023 - ACS Publications
We report on the synthesis and evaluation of three different nucleotide prodrug systems:(i)
nucleoside triphosphate analogues in which the γ-phosph (on) ate has two different …
nucleoside triphosphate analogues in which the γ-phosph (on) ate has two different …
Structure-based drug design of RdRp inhibitors against SARS-CoV-2
K Shehzadi, A Saba, M Yu, J Liang - Topics in Current Chemistry, 2023 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
Lipophilic Nucleoside Triphosphate Prodrugs of Anti‐HIV Active Nucleoside Analogs as Potential Antiviral Compounds
X Jia, D Schols, C Meier - Advanced Science, 2023 - Wiley Online Library
Nucleoside analogs require three phosphorylation steps catalyzed by cellular kinases to
give their triphosphorylated metabolites. Herein, the synthesis of two types of triphosphate …
give their triphosphorylated metabolites. Herein, the synthesis of two types of triphosphate …
Antiviral Activity of Lipophilic Nucleoside Tetraphosphate Compounds
X Jia, D Schols, C Meier - Journal of Medicinal Chemistry, 2024 - ACS Publications
We report on the synthesis and characterization of three types of nucleoside tetraphosphate
derivatives 4–9 acting as potential prodrugs of d4T nucleotides:(i) the δ-phosph (on) ate is …
derivatives 4–9 acting as potential prodrugs of d4T nucleotides:(i) the δ-phosph (on) ate is …
Membrane-permeable tenofovir-di-and monophosphate analogues
X Jia, GA Kullik, M Bufano, A Brancale, D Schols… - European Journal of …, 2024 - Elsevier
The development of new antiviral agents such as nucleoside analogues or acyclic
nucleotide analogues (ANPs) and prodrugs thereof is an ongoing task. We report on the …
nucleotide analogues (ANPs) and prodrugs thereof is an ongoing task. We report on the …
Potent Anti‐HIV Activity of Alkyl‐Modified DiPPro‐Nucleotides
X Jia, D Schols, C Meier - Small Structures, 2024 - Wiley Online Library
Two convergent approaches for synthesizing a new class of nucleoside diphosphate
prodrugs bearing different nucleoside analogs are reported herein. The DiPPro‐nucleotides …
prodrugs bearing different nucleoside analogs are reported herein. The DiPPro‐nucleotides …
Membrane permeable, bioreversibly modified prodrugs of nucleoside diphosphate-γ-phosphonates
X Jia, S Weber, D Schols, C Meier - Journal of Medicinal …, 2020 - ACS Publications
Nucleoside reverse transcriptase inhibitors (NRTIs) are widely used as antiviral and
anticancer agents, although they require intracellular phosphorylation into their antivirally …
anticancer agents, although they require intracellular phosphorylation into their antivirally …
Prodrugs of nucleoside 5'-monophosphate analogues: overview of the recent literature concerning their synthesis and applications
B Roy, V Navarro, S Peyrottes - Current Medicinal Chemistry, 2023 - ingentaconnect.com
Nucleoside analogues are widely used as anti-infectious and antitumoral agents. However,
their clinical use may face limitations associated with their physicochemical properties …
their clinical use may face limitations associated with their physicochemical properties …